P25440 (BRD2_HUMAN) Homo sapiens (Human)

Bromodomain-containing protein 2 UniProtKBInterProSTRINGInteractive Modelling

801 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4); 1 identical sequence: Gorilla gorilla gorilla: A0A2I2YDK8

Available Structures

161 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
BRD2-BD1 in complex with cyclic peptide 2.2B
8dnq
 Heteromer
72-187
3×GOL;
Assess
Crystal structure analysis of the N-terminal bromodomain of human BRD2 complexed with acetylated hi…
2dvq
 Heteromer
P02309; 		73-186
Assess
Crystal structure analysis of the N-terminal bromodomain of human BRD2 complexed with acetylated hi…
2dvr
 Heteromer
P02309; 		73-186
Assess
Solution structures of Brd2 second bromodomain in complex with stat3 peptide
5u5s
 Heteromer
P40763; 		344-455
Assess
Structure of human BRD2-BD1 bound to a histone H4 acetyl-methyllysine peptide
8sb6
 Heteromer
P62805; 		76-183
Assess
Crystal structure of the human Brd2 second bromodomain in complexed with the acetylated histone H4 …
2e3k
 Heteromer
P02309; 		348-455
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor Y13120
7wna
homo-6-mer346-455
6×JGR; 2×EDO; 2×PEG;
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor Y13157
7wmq
homo-4-mer345-455
4×JFL; 6×GOL; 15×FMT;
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor Y13153
7wln
homo-4-mer345-454
4×JFR; 1×DMS; 3×PEG; 4×GOL;
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor 22
8wyg
homo-4-mer345-454
4×XHN;
Assess
Crystal structure of BRD2(BD1)with ligand ZB-BD-224 bound
7dpn
homo-3-mer74-187
2×HFU;
Assess
N-Terminal Bromodomain of Human BRD2 With IBET-151
4alg
homo-2-mer72-189
2×ACT; 2×GOL; 2×1GH;
Assess
Crystal Structure of the human BRD2 BD1 bromodomain in complex with a Tetrahydroquinoline analogue
6ddi
homo-2-mer73-187
2×G7V; 1×SO4; 3×EDO; 1×03S;
Assess
N-Terminal bromodomain of Human BRD2 with a Tetrahydroquinoline analogue
6db0
homo-2-mer72-186
1×SO4; 2×G3J; 1×EPE;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5 ethyl-3-methyl-4-phenyl-1, 2-oxazole
4a9o
homo-2-mer74-188
2×EDO; 2×A9O; 2×SO4;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-cyclopropyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylb…
4a9n
homo-2-mer72-186
5×EDO; 2×A9N; 3×SO4;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-methyl-1,2,3,4- tetrahydroquinazolin-2-one
4a9i
homo-2-mer72-186
2×P9I; 2×SO4; 1×EDO;
Assess
Crystal structure analysis of the N-terminal bromodomain of human Brd2
1x0j
homo-2-mer73-186
2×DTT;
Assess
N-Terminal Bromodomain of Human BRD2 With tbutyl-phenyl-amino- dimethyl-oxazolyl-quinoline-carboxyl…
4akn
homo-2-mer73-186
1×EDO; 2×S5B; 2×SO4;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-methyl-1,2,3,4- tetrahydroquinazolin-2-one
4a9e
homo-2-mer73-186
2×3PF; 4×EDO; 2×SO4;
Assess
Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GSK525762 (IBET)
2yek
homo-2-mer74-187
2×EAM;
Assess
BRD2_Bromodomain1 complex with inhibitor 744
6ony
homo-2-mer73-186
2×EDO; 2×HWV;
Assess
Crystal structure analysis of the N-terminal bromodomain of human BRD2 complexed with acetylated hi…
2dvs
homo-2-mer73-186
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-cyclopentyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylb…
4a9m
homo-2-mer73-186
2×P9M; 2×SO4;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5-(4-(4-fluorophenyl)-1H-imidazol-5-yl)-1-methylpyridin-2…
6tq2
homo-2-mer73-186
2×SO4; 2×NUQ; 1×EDO;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 5-(1-(1,3-dimethoxypropan-2-yl)-5-morpholino-1H-benzo[d]i…
6tq1
homo-2-mer73-185
2×SO4; 2×NUH; 3×EDO;
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor Y13142
7wn5
homo-2-mer344-455
2×JGL; 5×EDO; 1×K;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-(2-methyl-1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one
4a9h
homo-2-mer75-186
2×EDO; 2×TVP; 1×SO4;
Assess
crystal structure of BRD2-BD1 in complex with guanosine analog
7vrh
homo-2-mer75-186
2×AC2; 1×DTT;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-METHYLPYRROLIDIN-2-ONE
4a9f
homo-2-mer75-185
2×MB3; 2×SO4; 1×EDO;
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor Y13158
7wni
homo-2-mer345-454
2×JGU; 4×EDO; 1×PEG;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3,5 dimethyl-4-phenyl-1,2- oxazole
4alh
homo-2-mer75-183
2×EDO; 2×A9P; 3×SO4;
Assess
crystal structure of BRD2-BD1 in complex with purine derivative
7vrz
homo-2-mer75-183
3×7UH; 2×SO4;
Assess
crystal structure of BRD2-BD1 in complex with purine derivative
7vro
homo-2-mer74-182
3×37T; 4×SO4;
Assess
Crystal structure of BRD2(BD2) mutant W370F in the free form
5dfb
homo-2-mer347-454
2×NI; 2×2PE; 2×GOL;
Assess
Discovery and the crystal structure of NS5 in complex with the N-terminal bromodomain of BRD2.
6jke
homo-2-mer75-182
1×BUX; 1×SO4; 1×DTT; 1×GOL; 1×DMS; 1×PGE;
Assess
Crystal structure of BRD2(BD1)with ligand BY27 bound
6k05
homo-2-mer76-183
2×CQF; 1×MES;
Assess
Crystal structure of pyrano 1,3, oxazine derivative in complex with the second bromodomain of BRD2
7eo5
homo-2-mer348-455
2×PGE; 2×BUX;
Assess
crystal structure of NS5 in complex with the N-terminal bromodomain of BRD2 (BRD2-BD1).
7env
homo-2-mer75-182
1×BUX; 1×SO4;
Assess
crystal structure of BRD2-BD1 in complex with purine derivative
7vrk
homo-2-mer75-182
3×TEP; 1×SO4;
Assess
crystal structure of BRD2-BD1 in complex with purine derivative
7vsf
homo-2-mer75-182
2×7UM; 1×EPE; 1×SO4;
Assess
crystal structure of BRD2-BD2 in complex with purine derivative
7vrm
homo-2-mer348-454
4×TEP;
Assess
crystal structure of BRD2-BD2 in complex with purine derivative
7vs1
homo-2-mer348-454
2×7UM; 2×GOL;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(4-hydroxyphenyl) acetamide
4a9j
homo-2-mer77-182
2×EDO; 2×TYL; 4×SO4;
Assess
Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GW841819X
2ydw
homo-2-mer77-181
2×WSH; 2×SO4;
Assess
BRD2-BD2 in complex with the cyclic peptide 4.2_3
6ult
homo-2-mer351-454
Assess
Solution structure of the Extraterminal (ET) Domain of BRD2
6cui
monomer621-750
Assess
BRD2-BD1 in complex with the cyclic peptide 3.2_2
6u8h
monomer65-190
6×IOD; 2×GOL; 1×NH2; 1×PE3;
Assess
BRD2-BD1 in complex with the cyclic peptide 4.2_3
6ulq
monomer65-190
Assess
Crystal structure of the N-terminus D161Y bromodomain mutant of human BRD2
5hem
monomer71-190
5×EDO; 1×ACT;
Assess
Crystal structure of the first bromodomain (BD1) of human BRD2 bound to volasertib
7lak
monomer73-192
1×IBI;
Assess
N-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A)
4uyf
monomer71-189
1×EDO; 1×73B; 1×SO4;
Assess
BRD2-BD1 in complex with the cyclic peptide 3.1_3
6u61
monomer70-187
2×ZN;
Assess
CRYSTAL STRUCTURE OF THE HUMAN BRD2 BD1 BROMODOMAIN IN COMPLEX WITH 9-(cyclopropylmethyl)-7-[(2R,6S…
5s9o
monomer73-190
1×YW1; 6×EDO;
Assess
Crystal structure of the N-terminus Y153H bromodomain mutant of human BRD2
5hel
monomer71-187
3×EDO;
Assess
N-terminal bromodomain of human BRD2 in complex with 4,4'-(quinoline-5,7-diyl)bis(3,5-dimethylisoxa…
6mo8
monomer74-187
2×JWD;
Assess
N-terminal bromodomain of human BRD2 in complex with N-cyclopentyl-7-(3,5-dimethylisoxazol-4-yl)qui…
6mo9
monomer74-187
2×JVY;
Assess
N-terminal bromodomain of human BRD2 with N-((4-(3-(N-cyclopentylsulfamoyl)-4-methylphenyl)-3-methy…
6mo7
monomer74-187
1×JWA;
Assess
Crystal structure of the human BRD2 BD1 bromodomain in complex with a BRD2-interactive compound, BI…
3aqa
monomer73-186
1×BYH; 1×MES;
Assess
X-ray crystal structure of bromodomain 2 of human brd2 in complex with rvx208 to 1.08 A resolution
4j1p
monomer344-455
1×1K0; 1×EDO;
Assess
Human Brd2(BD2) mutant in free form
5o38
monomer344-455
1×9JB; 1×CL; 1×DQW;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH (R)-N5-cyclopropyl-N3-methyl-2-oxo-1-(1-phenylethyl)-1,2-…
7npz
monomer344-455
3×EDO; 1×ULH;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH oxabicyclo(hexan-6-yl)-N2-methyl-6-((S)-1-phenylethyl)pyr…
7nq0
monomer344-455
3×EDO; 1×PE4; 1×ULN;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N5-((1R,5S,6r)-3-oxabicyclo[3.1.0]hexan-6-yl)-3-(1H-indol…
7oe8
monomer344-455
2×EDO; 1×V9Q;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1,5-dimethyl-N-(2-(methylamino)-2-oxo-1-(tetrahydro-2H-py…
7oet
monomer344-455
1×80Z; 3×EDO; 1×PE4;
Assess
Crystal structure of BRD2(BD2) mutant in free form
4qeu
monomer344-455
1×ACT; 1×GOL;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH GSK973
6z8p
monomer344-455
3×EDO; 1×1PG; 1×QC8;
Assess
Human BRD2 C-terminal bromodomain with (S)-1-(2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-6-(1,2,3,6-…
6ffg
monomer344-455
2×EDO; 1×D7B; 2×PEG; 1×MES;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH GSK620
6zb1
monomer344-455
2×EDO; 1×QCZ;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-(2-(benzyloxy)phenyl)-5-methyl-1H-1,2,4-triazole
7nq5
monomer344-455
3×EDO; 1×PE4; 1×ULB;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 6-((S)-hydroxy(phenyl)methyl)-N2-methyl-N4-((1S,2S)-2-met…
7nq1
monomer344-455
3×EDO; 1×ULK;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1,5-dimethyl-N-(2-(methylamino)-2-oxoethyl)-6-oxo-N-(2-ph…
7oes
monomer344-455
3×EDO; 1×PE4; 1×VBE;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 7,8-dimethoxy-1,3-dimethyl-1,3-dihydro-2H-benzo[d]azepin-…
8b5j
monomer344-455
3×EDO; 1×PE4; 1×P3R;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH (R)-7-((R)-1,2-dihydroxyethyl)-1,3-dimethyl-5-(1-methyl-1…
8b5h
monomer344-455
2×EDO; 1×7PE; 1×P4X;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N4-((1R,5S,6r)-3-oxabicyclo[3.1.0]hexan-6-yl)-6-((S)-meth…
7nq3
monomer344-455
3×EDO; 1×ULQ;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH iBET-BD2 (GSK046)
6swp
monomer344-455
2×EDO; 1×LW5;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 7,8-dimethoxy-1,3-dimethyl-1,3-dihydro-2H-benzo[d]azepin-…
8b5i
monomer344-455
4×EDO; 1×PE4; 1×P0U;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(2-(1H-imidazol-4-yl)ethyl)-4-acetamido-3-(benzyloxy)be…
6z7f
monomer344-455
2×PEG; 2×EDO; 1×QB5;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-benzyl-N-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide
6zb0
monomer344-455
1×EDO; 1×QCW; 1×MES;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1,3-dimethyl-5-(1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-b…
8px2
monomer344-455
1×NUB; 1×MES;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-methyl-4-propionyl-1H-pyrrole-2-carboxamide
7oe4
monomer344-455
4×EDO; 1×PE4; 1×V9B;
Assess
Human BRD2 C-terminal bromodomain with (S)-5-(1-acetyl-2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-1,…
6fff
monomer344-455
1×EDO; 1×MES; 1×D7H;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH (S)-N-ethyl-3-(1-methyl-1H-1,2,3-triazol-4-yl)-4-(1-pheny…
7nq7
monomer344-455
3×EDO; 1×UL8;
Assess
Crystal structure of BRD2(BD2) mutant with ligand ET bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)…
4qew
monomer344-455
1×GOL; 1×2PE; 1×31P; 1×NI;
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor Y13146
7wmu
monomer344-455
1×JGF; 1×EDO;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-ethyl-2-(1-methyl-1H-1,2,3-triazol-4-yl)-6-(1-phenyleth…
7nqj
monomer344-455
1×UME; 3×EDO; 1×PEG;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH (S)-N4-cyclopropyl-N2-methyl-6-(1-phenylethyl)pyridine-2,…
7nq2
monomer344-455
1×ULE; 2×EDO;
Assess
Human Brd2(BD2) mutant in complex with ME
5o39
monomer344-455
1×31O; 1×CL; 1×DQW;
Assess
Human BRD2 C-terminal bromodomain with 2-((4-acetyl-3-cyclopropyl-3,4-dihydroquinoxalin-1(2H)-yl)me…
6ffe
monomer344-455
2×PEG; 2×EDO; 1×D7Q;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5-(1-(1,3-dimethoxypropan-2-yl)-5-morpholino-1H-benzo[d]i…
7oep
monomer344-455
3×EDO; 1×PE4; 1×NV2;
Assess
Crystal structure of the second bromodomain (BD2) of human BRD2 bound to LRRK2-IN-1
7l9k
monomer344-455
1×BU1; 2×4K4;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH GSK549
6zb2
monomer344-455
3×EDO; 1×QD5; 1×PEG;
Assess
Human Brd2(BD2) mutant in complex with AL-tBu
5o3i
monomer344-454
1×9HN; 1×CL; 1×DQW;
Assess
Crystal structure of the BRD2-BD2 in complex with a ligand
7uu0
monomer344-454
1×EDO; 1×QJ1;
Assess
X-ray crystal structure of human BRD2(BD2) in complex with RVX297 to 1.55 A resolution
5dw1
monomer345-455
1×5GD;
Assess
Human Brd2(BD2) mutant in complex with 9-Me
5o3c
monomer345-455
1×9J2; 1×CL; 1×DQW;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 6-benzyl-N2-methyl-N4-((1S,2S)-2-methylcyclopropyl)pyridi…
7npy
monomer345-455
1×UL5; 3×EDO;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-ethyl-3-(1-methyl-1H-1,2,3-triazol-4-yl)-4-(pyridin-2-y…
7nq8
monomer345-455
3×EDO; 1×UM5;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-benzyl-N5-cyclopropyl-N3-methyl-1H-pyrazole-3,5-dicarbo…
7ogy
monomer345-455
4×EDO; 1×VE5; 1×PEG;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 2-benzyl-N-cyclopropyl-6-(1-methyl-1H-1,2,3-triazol-4-yl)…
7nqi
monomer345-455
1×UM8; 3×EDO;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 7,8-dimethoxy-3-methyl-1,3-dihydro-2H-benzo[d]azepin-2-one
8b5g
monomer345-455
2×EDO; 1×P4M; 1×MES;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N4-hydroxycyclohexyl-N2-methyl-5-phenylethyl-furan-2,4-di…
7oe6
monomer345-455
1×V9K; 2×EDO;
Assess
BRD2-BD1 in complex with MDP5
7usi
monomer73-183
1×O6O; 4×PEG; 5×EDO; 1×DMS; 1×CL; 1×NA;
Assess
Crystal structure of the second bromodomain (BD2) of human BRD2 bound to BI2536
7l9g
monomer346-455
2×EDO; 1×R78; 1×CL;
Assess
Crystal structure of BRD2 second bromodomain in complex with SGC-CBP30 chemical probe
5bt5
monomer346-455
4×EDO; 1×2LO;
Assess
Crystal structure of the second bromodomain (BD2) of human BRD2 bound to bromosporine
7l6d
monomer346-455
1×BMF; 8×EDO; 1×SO4;
Assess
Human Brd2(BD2) L383V mutant in complex with ET-JQ1-OMe
6ytm
monomer345-454
1×PMW; 2×PXN;
Assess
Human Brd2(BD2) mutant in complex with 9-ET
5o3d
monomer345-454
1×9J5; 1×CL; 1×DQW;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH iBET-BD1 (GSK778)
6swo
monomer346-455
1×LWB; 2×EDO;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH rac-N5-((1R,5S)-3-oxabicyclo[3.1.0]hexan-6-yl)-N7,3-dimet…
7oe9
monomer346-455
1×V9N; 2×EDO;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 2-benzyl-N-cyclopropyl-6-(1-methyl-1H-1,2,3-triazol-4-yl)…
7nq9
monomer346-455
1×UMB; 5×EDO;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N5-hydroxycyclohexyl-N3-methyl-1-phenylethyl-1H-pyrazole-…
7oe5
monomer346-455
1×V9H; 2×EDO;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(2,2-diphenylethyl)-1,5-dimethyl-N-(2-(methylamino)-2-o…
7oer
monomer346-455
1×VBH; 1×EDO;
Assess
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH (S)-5-(1-((1-acetylpiperidin-3-yl)methyl)-5-bromo-1H-benz…
8px8
monomer346-455
1×EDO; 1×MES; 1×I0U;
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with the inhibitor JQ1
3oni
monomer346-455
1×JQ1; 2×NI; 2×EDO;
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with a quinazolinone ligand (R…
4mr5
monomer346-455
4×EDO; 1×DMS; 1×1K0;
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with a quinazolinone ligand (R…
4mr6
monomer346-455
3×EDO; 1×DMS; 1×1K0;
Assess
Human Brd2(BD2) mutant in complex with ET-Am1
5o3f
monomer346-455
1×9HT; 1×CL; 1×DQW;
Assess
Crystal structure of BRD2(BD2) mutant with ligand ME bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)…
4qev
monomer346-455
1×31O; 1×2PE; 1×NI; 1×GOL;
Assess
Human Brd2(BD2) mutant in complex with AL-Am1
5o3g
monomer346-455
1×9J8;
Assess
Crystal structure of the second bromodomain (BD2) of human BRD2 bound to Ro3280
7l9j
monomer346-455
1×79C; 1×CL;
Assess
C-terminal bromodomain of human BRD2 in complex with 4-(2-cyclopropyl-7-(6-methylquinolin-5-yl)-1H-…
6moa
monomer346-454
1×JW4; 1×GOL;
Assess
Human Brd2(BD2) mutant in complex with 9-ME-Am1
5o3h
monomer346-454
1×9HQ; 1×CL; 1×DQW;
Assess
Crystal structure of the second bromodomain Q443H mutant of human BRD2
5hfq
monomer346-454
Assess
Human Brd2(BD2) mutant in complex with Me-Am1
5o3e
monomer346-454
1×9HW; 1×CL; 1×DQW;
Assess
BRD2-BD2 in complex with the cyclic peptide 3.1_3
6u71
monomer347-455
Assess
Crystal structure of BRD2(BD2) W370F mutant with ligand I-BET 762 bound
5dfc
monomer346-454
1×GOL; 1×2PE; 1×EAM; 1×NI;
Assess
Bromodomain-containing 2 BD2 in complex with the inhibitor CRCM5484
7q5o
monomer346-454
1×8M6; 3×EDO;
Assess
Peptide 2.2E in complex with BRD2-BD2
8cv7
monomer347-455
1×ACE; 1×NH2;
Assess
N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-((2R,4S)-2-methyl-4-(phenylamino)-6-(4-(piperidin-1-ylm…
4uyh
monomer75-183
1×9S3;
Assess
BRD2-BD2 in complex with a diacetylated-H2A.Z peptide
7jx7
monomer347-455
Assess
X-ray crystal structure of 1,2,3-triazolobenzodiazepine in complex with BRD2(D2)
5u6v
monomer347-455
1×7WY; 5×EDO;
Assess
Crystal structure of the N-terminus R100L bromodomain mutant of human BRD2
5hen
monomer75-183
1×EDO;
Assess
Crystal structure of the second bromodomain of human BRD2 in complex with a tetrahydroquinoline ana…
5n2l
monomer346-454
1×SO4; 2×EDO; 1×8J2;
Assess
C-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A)
4uyg
monomer347-455
1×73B; 2×SO4;
Assess
Ultra high resolution crystal structure of the apo- form of second bromodomain of BRD2.
5ibn
monomer348-455
1×CL; 5×GOL; 2×PGE;
Assess
Crystal Structure of the human BRD2 BD2 bromodimain in complex with a Tetrahydroquinoline analogue
6ddj
monomer348-455
1×G7V; 5×EDO;
Assess
Second bromodomain of Human BRD2 with a Tetrahydroquinoline analogue
6dbc
monomer348-455
7×EDO; 1×G3J;
Assess
Crystal Structure of the second bromodomain of BRD2 in complex with RT53
6i80
monomer348-455
1×H7B; 1×EDO;
Assess
BRD2-BD2 in complex with MDP5
7usg
monomer348-455
1×O6O; 2×EDO; 1×NA;
Assess
Crystal structure of BRD2(BD2)with ligand BY27 bound
6k04
monomer347-454
1×CQF;
Assess
BRD2-BD2 in complex with SF2523
7ush
monomer348-455
1×82V; 5×EDO;
Assess
Crystal structure of the BRD2-BD2 in complex with phenanthridinone
5xhk
monomer348-455
2×GOL; 1×2ME; 1×LDR;
Assess
Crystal Structure of the second bromodomain of human BRD2 in complex with the compound 3b
6wwb
monomer348-455
3×EDO; 1×YA3;
Assess
Crystal structure analysis of the second bromodomain of BRD2 covalently linked to b-mercaptoethanol
5xhe
monomer348-455
1×PGE; 3×GOL;
Assess
Crystal structure of BRD2(BD2) W370F mutant with ligand 28 bound
5dfd
monomer347-454
1×59E; 1×GOL;
Assess
Crystal structure of Phenanthredinone moiety in complex with the second bromodomain of BRD2 (BRD2-B…
7enz
monomer348-455
1×LDR; 1×PGE;
Assess
Crystal Structure of the second bromodomain of BRD2 in complex with RT56
6i81
monomer348-455
1×MES; 1×EDO; 1×H7E;
Assess
Crystal structure of the second bromodomain of the human Brd2 protein
2dvv
monomer348-455
1×EPE;
Assess
BRD2 Bromodomain2 with A-1360579
5uew
monomer347-454
1×87D;
Assess
Human Brd2(BD2) mutant in complex with AL
5o3b
monomer347-454
1×9HZ;
Assess
Crystal Structure of BRD2(BD2)with Ligand ZB-BD-224 bound
7dpo
monomer348-455
1×HFU;
Assess
Human Brd2(BD2) mutant in complex with ET
5o3a
monomer347-454
1×31P;
Assess
Solution structure of a Bromodomain from RING3 protein
2g4a
monomer348-455
Assess
Ultra-high resolution crystal structure of second bromodomain of BRD2 in complex with inhibitor 6B3
5ig6
monomer348-454
2×CL; 2×GOL; 1×6B3;
Assess
crystal structure of BRD2-BD2 in complex with purine derivative
7vrq
monomer348-454
1×37T; 1×GOL;
Assess
crystal structure of BRD2-BD2 in complex with purine derivative
7vs0
monomer348-454
2×7UH; 1×GOL;
Assess
crystal structure of BRD2-BD2 in complex with guanosine analog
7vri
monomer348-454
1×AC2;
Assess
BRD2_Bromodomain2 complex with pyrrolopyridone compound 27
6viy
monomer348-454
1×QYY;
Assess
Crystal structure of the second bromodomain of human BRD2 in complex with a tetrahydroquinoline inh…
5ek9
monomer348-454
1×5P4;
Assess
BRD2_Bromodomain2 complex with inhibitor 744
6e6j
monomer348-454
1×HWV;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8ov6.1.Cmonomer0.5576-454
62.92
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28ov6.1.Cmonomer0.5676-454
63.35
Assess
Isoform 38ov6.1.Cmonomer0.5529-407
63.24
Assess
Isoform 47uu0.1.Amonomer0.85224-334
1×QJ1;100.00
Assess